IL-18 attenuates experimental choroidal neovascularization as a potential therapy for wet age-related macular degeneration.

dc.contributor.author	SAUNDERS, SEAN	en
dc.date.accessioned	2016-06-22T12:20:00Z
dc.date.available	2016-06-22T12:20:00Z
dc.date.issued	2014	en
dc.date.submitted	2014	en
dc.identifier.citation	Doyle SL, Ozaki E, Brennan K, Humphries MM, Mulfaul K, Keaney J, Kenna PF, Maminishkis A, Kiang AS, Saunders SP, Hams E, Lavelle EC, Gardiner C, Fallon PG, Adamson P, Humphries P, Campbell M, IL-18 attenuates experimental choroidal neovascularization as a potential therapy for wet age-related macular degeneration., Science translational medicine, 6, 230, 2014, 230ra44	en
dc.identifier.issn	1946-6234	en
dc.identifier.other	Y	en
dc.description	PUBLISHED	en
dc.format.extent	230ra44	en
dc.relation.ispartofseries	Science translational medicine	en
dc.relation.ispartofseries	6	en
dc.relation.ispartofseries	230	en
dc.rights	Y	en
dc.title	IL-18 attenuates experimental choroidal neovascularization as a potential therapy for wet age-related macular degeneration.	en
dc.type	Journal Article	en
dc.type.supercollection	scholarly_publications	en
dc.type.supercollection	refereed_publications	en
dc.identifier.peoplefinderurl	http://people.tcd.ie/saundes	en
dc.identifier.rssinternalid	95792	en
dc.identifier.doi	http://dx.doi.org/10.1126/scitranslmed.3007616	en
dc.rights.ecaccessrights	openAccess
dc.identifier.orcid_id	0000-0003-1689-3598	en
dc.identifier.uri	http://hdl.handle.net/2262/76584

Browse